Generic Name and Formulations:
Permethrin 5%; crm.
Various generic manufacturers
Indications for Permethrin:
Adults and Children:
<2 months: not recommended. ≥2 months: massage into skin from head to soles of feet. Remove 8–14hrs later by washing. Usually 1 treatment suffices; if living mites are present after 14 days, retreat. Infants: also treat scalp, temples and forehead. Wash or dryclean bedding and clothing appropriately.
Allergy to pyrethrins, pyrethroids, or chrysanthemums.
Avoid eyes. Pregnancy (Cat.B). Nursing mothers: not recommended.
Pruritus, burning, stinging, tingling, numbness, erythema, rash.
Formerly known under the brand names Acticin, Elimite.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- In a Head-to-Head Battle, Brigatinib Appears to Best Crizotinib
- Durvalumab Shows Overall Survival Benefit in Patients With Stage III NSCLC
- Baseline Thrombopoietin Levels May Help Predict Response to ITP Treatment
- Despite Promising Trial Results, Skeptics Raise Red Flags About Anlotinib's Efficacy in Heavily Treated NSCLC
- Higher Risk of MGUS in Relatives of Patients With Multiple Myeloma Confirmed